Ziopharm Oncology reported $-8396000 in EBITDA for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Amgen AMGN:US $ 3341M 185M
AstraZeneca AZN:LN 4187M 687M
Baxter International BAX:US $ 911M 27M
Biogen BIIB:US $ 674.7M 20.2M
Bioline Rx BLRX:US $ -5.91M 0.52M
Bristol Myers Squibb BMY:US $ 5772M 404M
Corcept Therapeutics CORT:US $ 27.06M 9.9M
Curis CRIS:US $ -15.1M 2.57M
Eleven Biotherapeutics EBIO:US $ -0.82M 9.8M
Gilead Sciences GILD:US $ 3422M 1947M
GlaxoSmithKline GSK:LN 3120M 1062M
Immunogen IMGN:US $ -22.38M 11.71M
Intercept Pharmaceuticals ICPT:US $ -9.9M 10.55M
Intrexon XON:US $ -14.12M 3.05M
IONIS PHARMACEUT IONS:US $ -53.21M 278.25M
Johnson & Johnson JNJ:US $ 9309M 1549M
Karyopharm Therapeutics KPTI:US $ -34409000 81.51M
Merk MRK:US $ 6179M 492M
Novartis NOVN:VX SF 4552M 346M
Pfizer PFE:US $ 11182M 4046M
Ptc Therapeutics PTCT:US $ -60.21M 5.71M
Regeneron Pharmaceuticals REGN:US $ 1360.9M 1353.3M
Sangamo Biosciences SGMO:US $ -42.43M 5.29M
Tg Therapeutics TGTX:US $ -66.8M 26.07M
Verastem VSTM:US $ -16.95M 0.47M
YTE INCY:US $ 144.1M 9.29M
Ziopharm Oncology ZIOP:US $ -8.4M 1.21M